Tulobuterol is a β
2-adrenergic receptor agonist to induce relaxation of airway smooth muscle cells. The mechanism of action is explained as follows. Occupation of β
2-adrenergic receptors by tulobuterol results in the activation of the adenylyl cyclase (AC), leading to an increase in intracellular cyclic AMP [
A2381] and activation of protein kinase A (PKA). PKA phosphorylates Ca
2+-ATPase, resulting in opening of Ca
2+-activated K
+ channels, decreasing intracellular Ca
2+ concentration, and also decreased myosin light chain kinase (MLCK) activity. Tulobuterol transdermal patch as a controlled-release drug delivery system is used for medical purposes. (The product is for research purpose only.)